Clinical Trial Update: A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of oral AZD0233 vs placebo in healthy adult participants has been terminated; Dilated card…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• AZD0233

Snippet

Sponsor: AstraZeneca | Conditions: Dilated Cardiomyopathy | Phase 1 | Status: TERMINATED